Opaleye Management Inc.
Top Portfolio Positions
53 positions ·
$743,833,828 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio |
|---|---|---|---|---|
| HROW |
Harrow, Inc.
Healthcare
|
2,832,230 | $99,864,429 | 13.43% |
| LQDA |
Liquidia Corp
Healthcare
|
2,545,000 | $96,048,300 | 12.91% |
| ETON |
Eton Pharmaceuticals, Inc.
Healthcare
|
2,860,000 | $70,584,800 | 9.49% |
| SLGL |
Sol-Gel Technologies Ltd.
Healthcare
|
500,000 | $39,610,000 | 5.33% |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
390,000 | $32,826,300 | 4.41% |
| IRON |
Disc Medicine, Inc.
Healthcare
|
421,000 | $26,918,740 | 3.62% |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
1,430,000 | $25,711,400 | 3.46% |
| CBIO |
Crescent Biopharma, Inc.
Healthcare
|
1,312,615 | $24,112,737 | 3.24% |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
700,000 | $22,792,000 | 3.06% |
| CATX |
Perspective Therapeutics, Inc.
Healthcare
|
4,675,000 | $19,494,750 | 2.62% |
Portfolio Trend
Holdings in OCUL
Shares Held
Position Value (USD)
25 of 25 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,082,000 | 600,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,363,300 | 1,595,000 | Shares | Sole | 2026-04-13 | |
| 2025-09-30 | $18,645,550 | 1,595,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $14,801,600 | 1,595,000 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $11,691,350 | 1,595,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $37,084,950 | 4,342,500 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $43,717,500 | 5,025,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $36,303,300 | 5,307,500 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $60,543,555 | 6,653,138 | Shares | Sole | 2024-05-29 | |
| 2023-12-31 | $27,072,200 | 6,070,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $20,309,520 | 6,468,000 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $29,824,800 | 5,780,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $32,178,093 | 6,105,900 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $17,070,750 | 6,075,000 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $26,829,750 | 6,465,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $24,018,696 | 5,974,800 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $29,575,260 | 5,974,800 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $41,644,356 | 5,974,800 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $64,800,000 | 6,480,000 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $91,886,400 | 6,480,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $106,336,800 | 6,480,000 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $134,757,000 | 6,510,000 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $45,539,762 | 5,984,200 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $49,848,386 | 5,984,200 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $25,356,375 | 5,122,500 | Shares | Sole | 2020-05-15 | |
| No quarters match your search. | ||||||